Article

Construction and Validation of a Robust Genomic Classifier for High-Risk Sporadic Type 2 Papillary Renal Cell Carcinoma: Support More Accurate Utilization of mTOR inhibitors

2021-03-04

Abstract excerpt

To construct a robust genomic classifier for high-risk sporadic type 2 papillary renal cell carcinoma (sPRCC2) and identify potential therapeutic targets. A cohort from The Cancer Genome Atlas and two datasets from Gene Expression Omnibus were examined. Common differentially expressed genes were screened, and the ConsensusClusterPlus package was used to identify potential high-risk molecular subtypes of sPRCC2. Ta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e3cf394e-0a07-5f19-9208-98ab4e8fe294
DOI: 10.21203/rs.3.rs-264118/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest

Construction and Validation of a Robust Genomic Classifier for High-Risk Sporadic Type 2 Papillary Renal Cell Carcinoma: Support More Accurate Utilization of mTOR inhibitorsDOI 10.21203/rs.3.rs-264118/v1Read

Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art.Semantic proximity Read

Genome-wide mutation profiling and related risk signature for prognosis of papillary renal cell carcinomaSemantic proximity Read

Unveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysisSemantic proximity Read

Identification of Prognostic Biomarkers in Patients With Malignant Rhabdoid Tumor of the Kidney Based on mTORC1 Signaling Pathway-Related GenesSemantic proximity Read

Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial.Semantic proximity Read

PRRX1-TOP2A interaction is a malignancy-promoting factor in human malignant peripheral nerve sheath tumoursSemantic proximity Read

Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2α expression and cell proliferationSemantic proximity Read

Genetic variants in the mTOR pathway with renal cancer risk and subtypes in East Indian population.Semantic proximity Read

Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors.Semantic proximity Read

A HIF-Regulated VHL-PTP1B-Src Signaling Axis Identifies a Therapeutic Target in Renal Cell CarcinomaSemantic proximity Read